Leukemia & Lymphoma

Papers
(The H4-Index of Leukemia & Lymphoma is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Incidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulation77
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study41
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF)39
Impact of SF3B1 mutation in myelofibrosis35
Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma31
Successful treatment with bortezomib, thalidomide and dexamethasone in plasma cell myeloma post-bone marrow transplant30
CRLF2 and IKZF1 abnormalities in childhood hematological malignancies other than B-cell Acute Lymphoblastic Leukemia30
The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia24
CD19 expression is maintained in DLBCL patients after treatment with tafasitamab plus lenalidomide in the L-MIND study23
The inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review23
Embelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis23
Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma22
CD69 marks a subpopulation of acute myeloid leukemia with enhanced colony forming capacity and a unique signaling activation state22
Use of PD-1 blockade in refractory/relapsed natural killer T-cell lymphomas: a systematic review and synthesis of case reports21
Management of relapsed/refractory mantle cell lymphoma21
Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agents20
Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study20
Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust20
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination19
Cytogenetic abnormalities in NPM1-mutated acute myeloid leukemia19
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia19
Indolent B-cell non-Hodgkin lymphomas in children: high association with inborn errors of immunity19
Asparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management19
New therapies for angioimmunoblastic T-cell lymphoma: a comprehensive review and analysis19
0.10340023040771